Notice of Interim Results

Oxford, UK – 20 July 2015: Circassia Pharmaceuticals plc (“Circassia” or “the Company”) (LSE: CIR), a specialty biopharmaceutical company focused on allergy and asthma, will announce its interim results for the six months ended 30 June 2015 on Tuesday 28 July 2015.

An analyst meeting will take place at 9.30am at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD.  A webcast of the event will be available in the Media section of the Company’s website at www.circassia.com.

For further information please contact:

FTI Consulting
Mo Noonan
+44 (0) 20 3727 1390